The Registry to Observe Clinical Outcomes of Patients with High-risk Metastatic Hormone-naive Prostate Cancer in Japa
Not Applicable
- Conditions
- High-risk metastatic hormone-naive prostate cancer
- Registration Number
- JPRN-UMIN000037127
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 102
Inclusion Criteria
Not provided
Exclusion Criteria
1. Have any other active malignancies.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method